PD-1 expression has been recently reported as a marker of leukemic stem cells (LSCs) in T-ALL, and anti-PD1 treatment eliminates such LSCs in a cell-autonomous manner [53]. The gene discussed is PDCD1; the disease is acute lymphoblastic leukemia.